Most patients with coronary artery disease and peripheral vascular disease are on long-term antiplatelet therapy and dual therapy. Achieving a balance between ischemic and bleeding risk remains an important factor in managing patients on antiplatelet therapy. For most outpatient surgical procedures, maintenance and continuation of this therapy are recommended. Consultation with the patient's cardiologist, physician, and/or vascular surgeon is always recommended before interrupting or withholding this treatment modality.
Keywords: Angioplasty; Antiplatelet therapy; Aspirin; Bleeding; Cardiac stenting; Clopidogrel; Coronary artery disease; Myocardial infarction.
Copyright © 2016 Elsevier Inc. All rights reserved.